Understanding the A1C Test: What It Measures and Why It Matters

The hemoglobin A1C (HbA1c) test measures your average blood glucose over the preceding 2–3 months by assessing the percentage of hemoglobin glycated (glucose-attached). It is the primary tool for diagnosing prediabetes and diabetes and for monitoring long-term glycemic control.

What A1C Reflects

  • Red blood cells live ~120 days; glucose attaches irreversibly to hemoglobin A throughout their lifespan.
  • A1C represents a weighted average glucose, heavily influenced by the most recent 30–60 days.
  • Does not require fasting; can be drawn any time.

Diagnostic Thresholds (ADA / WHO)

CategoryA1CFasting Glucose2-hr OGTT
Normal<5.7%<100 mg/dL<140 mg/dL
Prediabetes5.7–6.4%100–125 mg/dL140–199 mg/dL
Diabetes≥6.5%≥126 mg/dL≥200 mg/dL

Confirm with repeat testing unless symptomatic with random glucose ≥200.

Who Should Be Tested

  • All adults ≥35 years (USPSTF) or ≥45 (ADA); earlier if overweight + risk factors.
  • Risk factors: BMI ≥25 (≥23 Asian Americans), family history, high-risk race/ethnicity (Black, Hispanic, Native American, Asian, Pacific Islander), hypertension, dyslipidemia, CVD, PCOS, prior GDM, physical inactivity, HIV, antipsychotic use.
  • Pregnant: Screen for GDM at 24–28 weeks; early if risk factors.
  • Children/adolescents: Overweight + ≥2 risk factors, starting at puberty or age 10.

Monitoring Targets (ADA)

  • General adult: <7% (53 mmol/mol).
  • More stringent (<6.5%): If achievable without hypoglycemia (e.g., newly diagnosed, long life expectancy, no CVD).
  • Less stringent (<8%): Severe hypoglycemia history, limited life expectancy, advanced complications, extensive comorbidities, long-standing difficult control.
  • Pregnancy: <6% (ideally <5.7% in 2nd/3rd trimester) if achievable without hypoglycemia.

Estimated Average Glucose (eAG)

Converts A1C to familiar mg/dL units:

  • 6% → 126 mg/dL
  • 7% → 154 mg/dL
  • 8% → 183 mg/dL
  • 9% → 212 mg/dL
  • 10% → 240 mg/dL

Limitations and Interferences

  • Falsely low: Hemolytic anemia, blood loss, transfusions, ESA therapy, pregnancy (2nd/3rd trimester), CKD (ESA), hemoglobin variants (HbS, HbC, HbE, HbF), high-dose vitamin C/E.
  • Falsely high: Iron deficiency anemia, B12/folate deficiency, uremia, hypertriglyceridemia, bilirubin, opioid use, certain hemoglobin variants.
  • Conditions requiring alternative monitoring: Hemoglobinopathies, hemolytic anemias, recent transfusion, pregnancy, ESRD—use fructosamine, CGM, or frequent glucose monitoring.

How to Lower A1C

  1. Medical nutrition therapy: Individualized carb management, Mediterranean/DASH/plant-based patterns, registered dietitian referral.
  2. Physical activity: 150 min/week aerobic + 2–3 resistance sessions; break up sitting time.
  3. Weight management: 5–10% loss improves insulin sensitivity dramatically.
  4. Medication optimization: Metformin first-line; add GLP-1 RA, SGLT2i, DPP-4i, insulin per guidelines—prioritize cardio-renal benefit.
  5. Technology: CGM (continuous glucose monitoring) for real-time feedback, time-in-range (TIR >70% ≈ A1C ~7%).
  6. Sleep, stress management, smoking cessation.

Frequency of Testing

  • Meeting target: every 6 months.
  • Not at target or therapy change: every 3 months.
  • Pregnancy: each trimester + postpartum.

A1C is a powerful population-level metric, but individual care requires integration with glucose patterns, hypoglycemia risk, comorbidities, and patient priorities. Partner with your care team for personalized goals.

Diabetes - Related Articles